Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Regeneus Ltd. ( (AU:CMB) ).
Cambium Bio Limited has reported its financial results for the year ending June 30, 2025. The company experienced a significant increase in revenue from ordinary activities, rising by 419% compared to the previous year. However, the net profit for the year showed a substantial decline, with a 70% decrease in profit from ordinary activities after income tax attributable to members. No dividends were proposed or paid for the current year. The company’s Annual General Meeting is scheduled for October 16, 2025, with director nominations due by September 10, 2025.
More about Regeneus Ltd.
Average Trading Volume: 15,262
Technical Sentiment Signal: Sell
Current Market Cap: A$8.04M
For an in-depth examination of CMB stock, go to TipRanks’ Overview page.